OR WAIT null SECS
November 02, 2008
This review provides an update of how dendrimer technology is being applied to the development of novel systems for various topical delivery applications.
Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
Novel hydrophobic bioadhesive polymers and dosage designs are now available to effectively achieve tailored release kinetics of a broad range of drugs to meet the clinical needs.
Pharma companies could benefit from the lessons learned in this fall's financial crisis.
Sophisticated excipient development, especially for coatings, is staying on top of new challenges and meeting expanding industry needs.
Pharmaceutical Technology will feature video coverage of AAPS this month.
November 01, 2008
Rapid advances in drug discovery have led to the identification of a number of compounds with good therapeutic potential.
October 30, 2008
Also, Maxygen looks to costs, jobs; Receptor BioLogix appoints Dale R. Pfost CEO; more...
October 23, 2008
Pfizer and UCB formed a technology company named Cyclofluidic with the aim of accelerating the drug-discovery process.